Vanda Pharmaceuticals Inc
VNDA4.520USD
+0.130+2.96%
收盘 09/18, 16:00（美东）报价延迟15分钟
267.04M总市值
亏损市盈率 TTM
关于 Vanda Pharmaceuticals Inc 公司
Vanda Pharmaceuticals Inc. 是一家生物制药公司，专注于开发和商业化疗法，以满足大量未满足的医疗需求并改善患者的生活。该公司的商业产品组合由三种产品组成：HETLIOZ，用于治疗非 24 小时睡眠-觉醒障碍 (Non-24) 和用于治疗史密斯-马吉尼斯综合征 (SMS) 的夜间睡眠障碍；Fanapt (伊潘立酮)，用于治疗 I 型双相情感障碍和用于治疗精神分裂症的长效注射剂 (LAI)；PONVORY (ponesimod)，用于治疗炎症/自身免疫性疾病，包括溃疡性结肠炎、牛皮癣、克罗恩病、特应性皮炎、嗜酸性食管炎和斑秃。该公司还正在开发一系列药物，包括 Tradipitant (VLY-686)、VHX-896、VSJ-110、VPO-227、VTR-297、VQW-765、VCA-894A 和 Type 2S (CMT2S)。
公司简介
公司代码VNDA
公司名称Vanda Pharmaceuticals Inc
上市日期Apr 12, 2006
CEODr. Mihael Hristos Polymeropoulos, M.D.
员工数量368
证券类型Ordinary Share
年结日Apr 12
公司地址Suite 300E
城市WASHINGTON
上市交易所NASDAQ Global Market Consolidated
国家United States of America
邮编20037
电话12027343400
网址https://www.vandapharma.com/
公司代码VNDA
上市日期Apr 12, 2006
CEODr. Mihael Hristos Polymeropoulos, M.D.
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Mihael Hristos Polymeropoulos, M.D.
Dr. Mihael Hristos Polymeropoulos, M.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
2.34M
+0.43%
Mr. Gunther Birznieks
Mr. Gunther Birznieks
Senior Vice President - Business Development
Senior Vice President - Business Development
411.63K
+73.26%
Mr. Kevin Patrick Moran
Mr. Kevin Patrick Moran
Chief Financial Officer, Senior Vice President, Treasurer
Chief Financial Officer, Senior Vice President, Treasurer
329.46K
+118.08%
Mr. Richard W. Dugan
Mr. Richard W. Dugan
Lead Independent Director
Lead Independent Director
177.45K
+50.09%
Dr. Tage Honore, Ph.D.
Dr. Tage Honore, Ph.D.
Independent Director
Independent Director
123.47K
+92.19%
Ms. Anne Sempowski Ward
Ms. Anne Sempowski Ward
Independent Director
Independent Director
119.07K
+98.97%
Dr. Stephen Ray Mitchell, M.D.
Dr. Stephen Ray Mitchell, M.D.
Independent Director
Independent Director
97.08K
+116.43%
Mr. Timothy I. Williams
Mr. Timothy I. Williams
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
--
--
Ms. Phaedra S. Chrousos
Ms. Phaedra S. Chrousos
Independent Director
Independent Director
--
--
Mr. Joakim (Kim) Wijkstrom
Mr. Joakim (Kim) Wijkstrom
Senior Vice President, Chief Marketing Officer
Senior Vice President, Chief Marketing Officer
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Mihael Hristos Polymeropoulos, M.D.
Dr. Mihael Hristos Polymeropoulos, M.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
2.34M
+0.43%
Mr. Gunther Birznieks
Mr. Gunther Birznieks
Senior Vice President - Business Development
Senior Vice President - Business Development
411.63K
+73.26%
Mr. Kevin Patrick Moran
Mr. Kevin Patrick Moran
Chief Financial Officer, Senior Vice President, Treasurer
Chief Financial Officer, Senior Vice President, Treasurer
329.46K
+118.08%
Mr. Richard W. Dugan
Mr. Richard W. Dugan
Lead Independent Director
Lead Independent Director
177.45K
+50.09%
Dr. Tage Honore, Ph.D.
Dr. Tage Honore, Ph.D.
Independent Director
Independent Director
123.47K
+92.19%
Ms. Anne Sempowski Ward
Ms. Anne Sempowski Ward
Independent Director
Independent Director
119.07K
+98.97%
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Fanapt
23.55M
47.05%
Hetlioz
20.87M
41.71%
PONVORY
5.62M
11.24%
暂无数据
业务
地区
业务USD
名称
营收
占比
Fanapt
23.55M
47.05%
Hetlioz
20.87M
41.71%
PONVORY
5.62M
11.24%
股东统计
更新时间: 8月15日 周五
更新时间: 8月15日 周五
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
10.13%
The Vanguard Group, Inc.
5.99%
Renaissance Technologies LLC
5.83%
Millennium Management LLC
5.28%
Dimensional Fund Advisors, L.P.
4.38%
其他
68.38%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
10.13%
The Vanguard Group, Inc.
5.99%
Renaissance Technologies LLC
5.83%
Millennium Management LLC
5.28%
Dimensional Fund Advisors, L.P.
4.38%
其他
68.38%
股东类型
持股股东
占比
Investment Advisor
27.77%
Investment Advisor/Hedge Fund
27.30%
Hedge Fund
19.35%
Individual Investor
7.19%
Research Firm
3.41%
Pension Fund
0.72%
Bank and Trust
0.20%
Sovereign Wealth Fund
0.19%
Venture Capital
0.05%
其他
13.82%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
417
50.75M
85.90%
-11.31M
2025Q1
426
48.51M
82.37%
-12.27M
2024Q4
444
46.48M
79.71%
-15.23M
2024Q3
446
47.42M
81.36%
-14.93M
2024Q2
445
46.99M
80.73%
-18.42M
2024Q1
434
53.50M
92.97%
-11.41M
2023Q4
445
55.38M
96.27%
-9.21M
2023Q3
446
56.79M
98.75%
-12.15M
2023Q2
434
60.42M
105.19%
-10.16M
2023Q1
437
62.04M
109.27%
-2.85M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
6.02M
10.21%
+16.86K
+0.28%
Mar 31, 2025
The Vanguard Group, Inc.
3.50M
5.93%
-11.00K
-0.31%
Mar 31, 2025
Renaissance Technologies LLC
3.57M
6.05%
-287.37K
-7.46%
Mar 31, 2025
Millennium Management LLC
3.12M
5.29%
+980.75K
+45.84%
Jun 27, 2025
Dimensional Fund Advisors, L.P.
2.54M
4.31%
+51.16K
+2.06%
Mar 31, 2025
BlackRock Financial Management, Inc.
2.15M
3.64%
+14.97K
+0.70%
Mar 31, 2025
Tang Capital Management, LLC
2.35M
3.99%
--
--
Mar 31, 2025
Polymeropoulos (Mihael Hristos)
2.33M
3.95%
+30.00K
+1.31%
May 21, 2025
Acadian Asset Management LLC
1.89M
3.2%
-12.95K
-0.68%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.61M
2.74%
+163.33K
+11.26%
Mar 31, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
